Menu Back toLS43: Experience of Implementation of De-Centralized Clinical Trial in Japan

18th DIA Japan Annual Meeting 2021

All prices are exclusive of 10% Japanese consumption tax

LS43: Experience of Implementation of De-Centralized Clinical Trial in Japan

Session Chair(s)

Tatsuya  Murakami

Tatsuya Murakami

  • Senior Director, Head of Clinical Operations
  • Pfizer R&D Japan G.K., Japan

Speaker(s)

Hiroya  Komoda

Hiroya Komoda

  • Clinical Project Manager, Clinical Project Management Group
  • Pfizer R&D Japan, Japan

Contact us